HeartSciences (HSCSW) Operating Leases (2022 - 2026)

HeartSciences (HSCSW) has reported Operating Leases for 5 consecutive years, with $175501.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Leases fell 44.2% year-over-year to $175501.0; the trailing twelve-month figure through Apr 2026 stood at $175501.0 (down 44.2% YoY), and the FY2026 full-year result was $175501.0, down 44.2% from the prior year.
• Operating Leases retreated to $175501.0 in Q2 2026 per HSCSW's latest filing, from $314527.0 in the prior quarter.
• Across five years, Operating Leases topped out at $583016.0 in Q1 2023 and bottomed at $175501.0 in Q2 2026.
• Historically, Operating Leases has averaged $401581.9 across 5 years, with a median of $405743.0 in 2024.
• The sharpest annual moves came in 2023 and 2026: Operating Leases declined 11.35% in 2023, then plunged 44.2% in 2026.
• Over 5 years, Operating Leases stood at $549227.0 in 2022, then dropped by 11.35% to $486885.0 in 2023, then declined by 22.72% to $376241.0 in 2024, then slipped by 16.4% to $314527.0 in 2025, then slumped by 44.2% to $175501.0 in 2026.
• According to Business Quant data, Operating Leases over the past three periods registered $175501.0, $314527.0, and $247263.0 for Q2 2026, Q4 2025, and Q4 2025 respectively.